Safety and Efficacy by Multiple Injection of KH902 in Patients With Diabetic Macular Edema (DME)

NCT01324869 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

BIOLOGICAL: KH902

Sponsor

Chengdu Kanghong Biotech Co., Ltd.

Collaborators

[object Object]
[object Object]